Opinion|Videos|December 20, 2024

Important Background Information on RSV for Pharmacists

Traci M. Poole, PharmD, BCACP, BCGP, discusses the pathophysiology of respiratory syncytial virus (RSV) and its key complications, identifies high-risk populations for severe RSV infection, and explores best practices for recognizing these patients and ensuring they receive timely vaccination to prevent serious outcomes.

Video content above is prompted by the following:

  1. What is the pathophysiology of RSV, and what key complications may occur?
  2. What are the high-risk populations for getting severe RSV infection?
  3. What are the best practices for identifying these patients and ensuring they are vaccinated against RSV?

Latest CME